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Abstract
Background: Patient choice and access to health care is compromised by many barriers including travel
distance. Individuals with the human immunodeficiency virus (HIV) can seek free specialist care in Britain,
without a referral, providing flexible access to care services. Willingness to travel beyond local services
for preferred care has funding and service implications. Data from an enhanced HIV surveillance system
were used to explore geodemographic and clinical factors associated with accessing treatment services.
Methods: We extracted data on the location, type and frequency of care services utilized by HIV positive
persons (n = 3983) accessing treatment in north west England between January 1st 2005 and June 30th 2006.
Individuals were allocated a deprivation score and grouped by urban/rural residence, and distance to care
services was calculated. Analysis identified independent predictors of distance travelled (general linear
modelling) and, for those bypassing their nearest clinic, the probability of accessing a specialist service
(logistic regression, SPSS ver 14). Inter-relationships between variables and distance travelled were
visualised using detrended correspondence analysis (PC-ORD ver 4.1).
Results: HIV infected persons travelled an average of 4.8 km (95% confidence intervals (CI) 4.6–4.9) per
trip and had on average 6 visits (95% CI 5.9–6.2) annually for care. Longer trips were made by males (4.8
km vs 4.5 km), white people (6.2 km), the young (>15 years, 6.8 km) and elderly (60+ years, 6.3 km), those
on multiple therapy (5.3 km vs 4.0 km), and the more affluent living in rural areas (16.1 km, P < 0.05). Half
the individuals bypassed their nearest clinic to visit a more distant facility, and this was associated with
being aged under 20 years, multiple therapy, being a male infected by sex between men, relative wealth,
and living in rural areas (P < 0.05). Of those bypassing local facilities, poorer people were more likely to
access a specialist centre but did not have as far to travel to do so (3.6 km) compared to those from less
deprived areas (8.6 km).
Conclusion: Distance travelled, and type of HIV services used, were associated with socioeconomic
status, even after accounting for ethnicity, route of infection and age. Thus despite offering an 'equitable'
service, travel costs may advantage those with higher income.
Published: 6 March 2009
BMC Public Health 2009, 9:78 doi:10.1186/1471-2458-9-78
Received: 13 May 2008
Accepted: 6 March 2009
This article is available from: http://www.biomedcentral.com/1471-2458/9/78
© 2009 Cook et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Public Health 2009, 9:78 http://www.biomedcentral.com/1471-2458/9/78
Page 2 of 12
(page number not for citation purposes)
Background
Tudor Hart formulated the inverse care law when he
observed that people with the greatest healthcare needs
often received the least adequate healthcare [1]. More
than three decades later, those in lower socio-economic
groups and minority ethnic groups continue to have
reduced secondary and tertiary medical care compared
with white people and the more affluent [2,3]. When a
selection of such persons were presented with a theoreti-
cal clinical vignette of different health care options, how-
ever, their choices were similar to that made by more
advantaged groups [2]. Long distance travel is recognised
to be an important factor limiting patient choice and
access [4,5]. The Patient Choice Project was established to
offer patients using the UK's National Health Service more
choice over where and when they receive treatment, and
to reduce waiting times [6]. Thirty percent of respondents
consistently chose 'current' over 'alternative' hospital care.
Age, education and income had an important effect on the
uptake of choice. Patient choice can override access barri-
ers, and data from the USA revealed that more than half of
patients surveyed in West Virginia bypassed local for more
distant services [7]. Factors associated with bypass
included age, income, and dissatisfaction with local serv-
ices. Lack of specialty care, limited services, and the value
of local services were most frequently mentioned.
Current UK health policy has a focus on 'patient choice'
for hospitals in which they would like to be treated [8]. It
is unclear whether choice of provider leads to less equity
(the less advantaged may be less able to choose) or
increased equity (everyone can access the same quality of
service regardless of where they live). Key factors influenc-
ing a patient's willingness to travel beyond their local serv-
ices for treatment include specialist care, reputation of
hospital/surgeon, seriousness or urgency of condition,
infrequent need of service, and being male and affluent
[9]. Reluctance to travel is associated with being of black/
minority ethnicity, and having responsibilities such as
children [9]. However, such reviews have not considered
other aspects of individual choice such as the need to pre-
serve anonymity, as may be the case when people have
stigmatised conditions such as sexually transmitted infec-
tions including HIV.
Persons infected with HIV are included among those most
in need of high quality and accessible healthcare [10]. In
the USA, barriers to care were identified for HIV positive
patients accessing care, including the need of rural popu-
lations to travel great distances to maintain anonymity
[11]. Socioeconomic factors and severity of HIV illness
predicted use of outpatient care [12]. When universal
transportation was made available to HIV patients for out-
patient care in Colorado, distance to care no longer pre-
dicted poorer participation or retention by the least
wealthy [13].
To preserve anonymity, individuals in the UK can self-
refer to specialist services for treatment of sexually trans-
mitted infections, including HIV care. HIV positive indi-
viduals thus have considerable flexibility as to where they
access services, without referral, and may choose to boy-
cott a local centre and travel a significant distance for
treatment. Many, however, reside far from a treatment
centre and have no choice but to travel. Moreover, the
extent to which they exercise this choice is likely to
depend on a number of issues, such as the severity of ill-
ness, their economic status, and their ability to travel to
services. Data from HIV services, thus, provide a unique
opportunity to evaluate factors affecting a person's choice
of services. In addition, willingness to travel beyond local
services for preferred care has funding and service implica-
tions.
The north west of England has had an enhanced surveil-
lance system for HIV since 1996, collating information on
demographics and use of health care services from genito-
urinary medicine (GUM) clinics, infectious disease
departments, haematology units and a number of other
specialist units and clinics. The region covers some
densely populated urban areas to the south (e.g. Mersey-
side; 2118 per km2), and some sparse rural areas to the
north (e.g. Cumbria; 73 per km2), making it an interesting
case study for travel to HIV services. The aim of this study
was to explore socio-geographic factors that may influ-
ence patients' access to HIV treatment and care services.
Distance travelled by HIV positive individuals for treat-
ment was investigated to determine whether patients'
socio-demographic backgrounds (age, ethnicity, level of
deprivation), and their disease status (route of infection,
use of antiretrovirals) impact on service choice. Assuming
that individuals exercise choice over service provider,
analyses at clinic level are used to determine how far peo-
ple are prepared to travel to clinics offering a perceived
quality of services.
Methods
Data extraction and distance calculations
The enhanced HIV surveillance system measures level of
use of health services, demographics, place of residence
and treatment variables. Pseudoanonymised identifiers
are recorded in order to prevent double counting of indi-
viduals attending more than one treatment centre. Data
are collected every six months, and include a summary of
the care from each clinic. A subset of the variables from
the hospital dataset is submitted to the national HIV sur-
veillance system (survey of prevalent HIV infections diag-
nosed – SOPHID). Data collection and storage conform
to all relevant laws and guidance relating to security andBMC Public Health 2009, 9:78 http://www.biomedcentral.com/1471-2458/9/78
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confidentiality. The ethical approval governing the main-
tenance and development of the surveillance system
incorporate data extraction for monitoring and research
purposes. For this study, data were extracted from the rou-
tinely collected data of all HIV positive persons accessing
treatment in an eighteen month period (1st January 2005
to 30th June 2006; n = 4721). Of these, 718 (15.2%) were
excluded for lack of post code information or for being
resident outside the north west region, and a further 20
because they had not attended outpatient clinics (having
had an episode of admission to hospital only), leaving
data on 3983 individuals for analysis. Only HIV-specific
care was included since the system does not collect data
on other care, e.g. antenatal care.
The distance to all clinics offering HIV care in the north
west was calculated by taking a straight line distance from
the area of residence to the clinics (using postal code data)
[14]. Analyses were carried out on the distance travelled
per trip, but to calculate total travel burden the distance
travelled for HIV care in a year was also calculated by mul-
tiplying the number of visits (for both day cases and out-
patient episodes) to each location by the distance to that
location. For total travel burden, distance travelled is pre-
sented as return journeys during a one-year period. Dis-
tances travelled were adjusted for those patients who were
new to the database at some point after the first data col-
lection period (i.e. if someone had attended only for the
most recent six months their travel distance was doubled
to make their yearly travel). The nearest clinic was also cal-
culated, so that a comparison could be made between
how far each person would have needed to travel to the
nearest clinic and how far they actually travelled, with
analyses by subgroup on these bypass distances. Clinics
that did not offer general HIV care, and non-prescribing
clinics, were excluded from this nearest clinic calculation.
Socio-demographic variables
The North West Public Health Observatory provided
Index of Multiple Deprivation (IMD) scores and rural/
urban categories for each lower super output area (LSOA)
of residence. Deprivation scores were ranked into three
equally sized categories (least deprived, average, most
deprived). Because 93% of people with HIV in the non-
urban areas fell into the least deprived category, with the
remaining 7% in the average category, those living in non-
urban areas were coded as 'not urban least deprived', with
a mean IMD of 15.3. Individuals from urban areas were
split into the three deprivation groups: urban least
deprived (IMD of less than 33), urban average (IMD
between 33 and 57) and urban most deprived (IMD
greater than 57).
Other socio-demographic variables of interest were gen-
der, age, ethnicity category, and British residency. Each
person's HIV status, in terms of route of infection, pre-
scription of antiretroviral treatment, and year of treatment
initiation, were accessible through the enhanced surveil-
lance system.
Statistical analyses
Variables of interest in individual subjects (n = 3983)
monitored were: (i) per trip distance travelled in kilome-
tres; (ii) whether or not the individual had travelled fur-
ther than their closest service, (iii) for individuals (n =
1980) who travelled further than they needed to, the dif-
ference in distance between a journey to the nearest clinic
and their actual travel distance, (iv) for those 1980 travel-
ling further than they needed to, the type of service
accessed (centre of excellence/specialist service or not).
Distance travelled and distance if travelling to the nearest
clinic were positively skewed and were thus log trans-
formed (natural logs) to improve normality for analysis of
variance (ANOVA) and general linear modelling (GLM:
an analysis of variance technique, SPSS ver 14). The trans-
formation procedure resulted in 69.9% of data points
lying within one standard deviation of the mean (com-
pared to 68.3% for a theoretical normal distribution, and
contrasts with 92.5% for the highly skewed original data).
Summary data are converted back to kilometres for dis-
play, resulting in asymmetrical confidence intervals that
represent the skew in the underlying data. ANOVA was
carried out separately for each variable in turn, displaying
the F statistic (see Additional File 1), degrees of freedom
and associated probability for each test. Then, because
many variables are related (e.g. route and sex – those
infected with HIV through sex between men are, by defi-
nition, men) variables were combined and entered into a
single GLM to identify independent predictors of distance
and extra distance travelled. In the case of significant dif-
ferences between groups, posthoc comparisons were used
to identify where the significant differences occurred
(Bonferroni multiple comparisons). Individuals were also
coded as to whether they bypassed their local service and
travelled further (extra travel) or not. The probability of
bypassing the nearest clinic was analysed using backwards
stepwise logistic regression. For those bypassing the near-
est clinic, the probability of attending an excellent/spe-
cialist centre was also analysed by logistic regression.
Analyses were carried out in SPSS (SPSS for Windows,
Release 14.0; SPSS Inc).
In order to understand the inter-relationships between the
variables and the distance travelled, a multivariate analy-
sis technique (detrended correspondence analysis – DCA)
was used to visualise the separation (or otherwise) of the
individuals in two dimensions (i.e. scores along the two
major axes of variation, based on all the measured varia-
bles) [15]. The use of two sets of axis scores enables aBMC Public Health 2009, 9:78 http://www.biomedcentral.com/1471-2458/9/78
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greater degree of visualisation of groupings than does the
production of a single similarity matrix (e.g. as in cluster
analysis). The first axis (axis 1) is the axis of greatest vari-
ation between individuals and provides a visualisation of
all individuals (based on all of the measured variables)
such that individuals with the most dissimilar profiles are
found at the opposite extremes of the axis. Subsequent
axes provide further separation by identifying the next
largest axes of variation between individuals. Since succes-
sive axes exhibit a decreasing separation between individ-
uals, it is common practice to use only two (or sometimes
three) such axes. We have displayed the first two axes on
a biplot (i.e. those axes that enable the maximum visuali-
sation of variation). The axes are displayed in units of
standard deviation (by convention multiplied by 100).
DCA enables individuals to be arranged graphically on
the basis of their similarity based on a large number of
variables. Thus, this analysis allows us to visualise this
complex dataset and to identify where separation between
individuals lies. Subsequently, particular variables can be
identified with particular groupings of individuals (we
looked at each variable in turn to select the one that best
described the separation between groups of individuals).
In addition, the distribution of individuals along the axes
can be correlated with a linear variable (in this case dis-
tance travelled). DCA was carried out using PC-ORD ver
4.1 [16].
Results
Distance travelled and number of visits
In a population of 3983 persons infected with HIV in
north west England, the distances travelled to seek HIV
care differed significantly according to socio-economic
and demographic characteristics (Table 1). Individuals
visited an average of 6 times (95% confidence intervals
(95% CI) 5.9–6.2) and travelled an average of 4.8 km
(95%CI 4.6–4.9) to their clinic. The average total return
distance travelled per year for all clinic visits was 57.6 km
(95% CI 55.4 – 59.5). Males travelled significantly further
than females per trip (4.8 vs 4.5 km; P = 0.037), and indi-
viduals classified as white travelled further (5.1 km) than
black African (4.0 km) and black Caribbean groups (3.1
km; multiple comparison P < 0.05). Those infected
through blood/tissue and children infected from their
mothers travelled the furthest (13.9 km and 7.2 km
respectively), whilst those infected through heterosexual
sex travelled the shortest distance (4.5 km; multiple com-
parisons P < 0.05). Although statistically significant, the
magnitude of the difference between number of visits by
category was small, ranging from 5 visits by individuals
infected through injecting drug use to 7 visits by children
infected by vertical transmission (P < 0.001).
Those taking antiretroviral drugs travelled significantly
further than those not taking therapy (5.3 km per trip for
those on four or more drugs and 5.2 km for those on three
drugs, vs 4.0 km for those on none; multiple comparisons
P < 0.05). This group also visited more frequently, with
those on four or more antiretroviral drugs visiting on aver-
age 8 times a year and travelling a total of 85.3 km a year
in round trips, compared with 5 visits made by those on
no therapy (P < 0.001), and an annual travel burden of
38.3 km. People not yet taking therapy would be expected
to visit clinics regularly for routine monitoring.
Age was a significant predictor of per trip travel, with the
youngest (<15 years old) and the oldest (>59 years) age
groups travelling significantly further per trip (6.8 km and
6.7 km respectively) compared with those of intermediate
age (e.g. 4.2 km for those aged 30 to 34 years) (multiple
comparisons P < 0.05). Individuals living in more rural
areas travelled more than twice as far (16.1 km per trip)
than those of equivalent affluence in urban areas (6.6
km). Individuals living in the most deprived urban areas
travelled only 3.4 km per trip (all multiple comparisons P
< 0.05). Those living in urban areas did not visit more fre-
quently, and there was no difference in the number of vis-
its by deprivation (P = 0.186). The per-trip distance
travelled showed a similar pattern to the total annual dis-
tance travelled in a year (Table 1).
The independent relationships with per trip distance trav-
elled shown in table 1 were confirmed using GLM. All the
variables listed in table 1 were used in the GLM, but some
were combined and categories were collapsed to achieve
sufficient sample sizes in subgroups. These analyses are
summarised here but not presented in a table. The analy-
ses confirmed that distance travelled differed between the
combined infection route and gender categories (F3,3969 =
10.3, P < 0.001). After post hoc multiple comparisons,
only those in the 'other' category (including children,
those infected through blood products and injecting drug
users) travelled significantly further than all other catego-
ries (P < 0.05). Ethnicity and residency status were com-
bined with the result that white UK nationals travelled
significantly further than black African UK nationals and
all categories of non-UK nationals (F5,3969 = 3.9, P = 0.002,
multiple comparisons P < 0.05).
There was an overall effect of level of drug therapy (F2,3969
= 26.2, P < 0.001), and those taking antiretroviral therapy
travelled significantly further than those not on therapy
(multiple comparisons P < 0.05), although those on four
or more drugs travelled no further than those taking three
drugs (multiple comparisons P > 0.05). The strongest pre-
dictor of travel distance was deprivation/urban category
(F3,3969 = 166.2, P < 0.001), confirming the findings in
table 1, and with all categories differing significantly from
each other (multiple comparisons P < 0.05). Age did not
remain significant in the final model.BMC Public Health 2009, 9:78 http://www.biomedcentral.com/1471-2458/9/78
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Table 1: Differences between demographic and infection groups in number of visits and distance travelled for HIV treatment
N Total no. visits F Per trip distance km F Total yearly return km F
Sex 2.1 4.2* 6.9**
Male 2945 6.1 (5.9, 6.2) 4.8 (4.7, 5.0) 59.2 (57.0, 62.1)
Female 1038 5.8 (5.6, 6.1) 4.5 (4.3, 4.8) 53.1 (49.2, 57.0)
Age (years) 5.7*** 4.9*** 9.7***
0–14 67 6.8 (5.9, 8.0) 6.8 (5.6, 8.0) 92.9 (74.4, 116.0)
15–19 27 7.4 (5.6, 9.8) 4.5 (3.1, 6.3) 65.8 (39.9, 108.6)
20–24 165 5.5 (4.9, 6.2) 4.3 (3.7, 5.0) 47.3 (40.1, 55.8)
25–29 467 5.6 (5.2, 6.0) 4.2 (3.9, 4.5) 47.2 (42.5, 52.5)
30–34 674 5.4 (5.1, 5.7) 4.2 (3.9, 4.5) 45.4 (41.0, 50.1)
35–39 851 5.7 (5.5, 6.1) 4.8 (4.5, 5.1) 55.2 (50.9, 59.7)
40–44 762 6.5 (6.1, 6.8) 5.0 (4.7, 5.5) 64.9 (59.5, 70.7)
45–49 439 6.9 (6.5, 7.3) 5.1 (4.7, 5.6) 70.2 (63.2, 77.7)
50–54 270 6.4 (5.8, 6.9) 5.1 (4.7, 5.8) 66.0 (57.8, 75.5)
55–59 138 6.2 (5.5, 7.0) 5.6 (4.7, 6.6) 69.0 (56.3, 84.7)
60+ 123 6.7 (6.0, 7.4) 6.3 (5.3, 7.6) 84.8 (69.7, 103.2)
Ethnicity 2.7** 12.0*** 12.2***
White 2649 6.1 (6.0, 6.3)a 5.1 (5.0, 5.3)ae 63.7 (60.8, 66.6)a
Black Caribbean 45 6.5 (5.2, 8.2)a 3.1 (2.3, 4.0)bc 38.9 (27.4, 55.4)abcd
Black African 1082 5.8 (5.5, 6.0)ab 4.0 (3.7, 4.2)bd 46.0 (42.8, 49.2)cd
Black Other 15 6.5 (4.7, 9.0)ab 3.7 (2.4, 5.5)acd 47.3 (29.3, 77.2)abcd
Indian/Pakistani/Bangladeshi 48 5.5 (4.6, 6.6)ab 4.8 (3.7, 6.6)acd 54.1 (37.3, 78.2)bcd
Other Asian/Oriental 46 5.5 (4.2, 7.1)ab 6.8 (5.0, 9.3)a 74.7 (48.6, 114.9)bd
Other/Mixed 75 6.0 (5.1, 7.1)ab 5.5 (4.3, 7.1)ad 66.0 (48.9, 89.2)bcd
Unknown 23 3.6 (2.5, 5.1)b 2.9 (1.4, 5.3)cde 20.3 (9.3, 44.4)bcd
Route of Infection 5.1*** 17.1*** 15.2***
Sex between men 2172 6.3 (6.1, 6.5)ab 4.8 (4.7, 5.0)ab 60.2 (57.0, 63.1)a
Injecting drug use 94 5.3 (4.5, 6.2)ab 5.1 (4.2, 6.3)abc 53.1 (41.5, 68.6)ab
Heterosexual 1526 5.7 (5.5, 6.0)ab 4.5 (4.2, 4.7)ab 51.2 (48.0, 54.4)bBMC Public Health 2009, 9:78 http://www.biomedcentral.com/1471-2458/9/78
Page 6 of 12
(page number not for citation purposes)
Separation between groups of individuals
Simultaneous expression of all variables (age, sex, ethnic-
ity, residential status, urbanisation category, deprivation
and infection route) in two dimensions (using DCA), dis-
tinguishes four main groups in the scatter plot (Figure 1).
Although all variables were included in the analysis, indi-
viduals have been labelled by infection route since this
variable demonstrates a clear separation between the data
points. Children infected through vertical transmission lie
in the top right of the graph, while those nearer the bot-
tom left are those infected through injecting drug use and
sex between men. Those to the bottom right tend to be
heterosexual. Many of the variables are interrelated, for
example men who have sex with men (MSM) tend to be
white and older, while non-white adults tend to be heter-
osexual and younger (groupings not illustrated here). Dis-
Blood/tissue 57 5.9 (5.0, 7.0)ab 13.2 (10.1, 17.2) 156.4 (114.9, 212.4)c
Mother to child 71 7.2 (6.2, 8.3)a 7.2 (6.1, 8.5)bc 104.0 (84.3, 128.1)c
Other/unknown 63 4.9 (3.9, 6.1)b 5.8 (4.5, 7.2)abc 56.0 (39.6, 78.9)ab
Residency 5.0*** 18.5*** 22.2***
UK 2997 6.1 (6.0, 6.3)a 5.1 (5.0, 5.3) 63.4 (60.8, 66.0)
Asylum Seeker 367 5.5 (5.1, 6.0)ab 3.7 (3.4, 4.2)a 41.8 (37.0, 47.0)a
Overseas Student 109 5.2 (4.5, 6.0)ab 3.5 (2.9, 4.2)a 35.7 (28.6, 44.4)a
Other non-UK 244 6.4 (5.8, 6.9)ab 4.0 (3.5, 4.5)a 50.5 (43.8, 58.3)a
Unknown 266 5.3 (4.8, 5.9)b 3.9 (3.4, 4.3)a 41.2 (35.1, 48.0)a
Level of antiretroviral 
therapy
147.3*** 28.9*** 138.4***
None 1333 4.7 (4.5, 4.9) 4 (3.9, 4.3) 38.3 (35.7, 40.9)
Mono+, dual+, triple 1935 6.4 (6.2, 6.6) 5.1 (5.0, 5.5)a 66.0 (62.8, 69.5)
Quadruple or more 715 8.1 (7.7, 8.5) 5.3 (4.8, 5.6)a 85.3 (78.9, 92.4)
Deprivation and urban 
category
1.6 198.1*** 122.9***
Not urban, least deprived 150 5.4 (4.8, 6.0) 16.1 (14.2, 18.3)T 173.5 (146.5, 205.0)T
Urban, least deprived 1192 6.1 (5.9, 6.4) 6.6 (6.3, 6.9)T 80.8 (75.3, 86.3)T
Urban, average deprivation 1347 6.1 (5.8, 6.3) 4.3 (4.2, 4.7)T 52.8 (49.6, 56.3)T
Urban, most deprived 1294 5.9 (5.7, 6.2) 3.4 (3.2, 3.5)T 40.6 (38.3, 43.1)T
Total 3983 6.0 (5.9, 6.2) 4.8 (4.6, 4.9) 57.6 (55.4, 59.5)
Figures in brackets are lower and upper confidence intervals. Univariate analysis, ANOVA and means calculated on log transformed variables.
Total mileage is return mileage, and does not equate to number of visits multiplied by length of a single journey, since individuals may have used 
more than one treatment centre.
+9 individuals on dual, 1 on mono therapy.
Means in the same group with the same superscript letter do not significantly differ after post hoc analysis (Bonferroni multiple comparisons). 
Multiple comparisons by age are too complex to show here, but are typified by those in the youngest and oldest age groups being significantly 
higher than those in the 25 to 34 year age groups.
all means significantly different from each other after Bonferroni multiple comparisons
*** P < 0.001, ** P < 0.01, * P < 0.05
Table 1: Differences between demographic and infection groups in number of visits and distance travelled for HIV treatment (Continued)BMC Public Health 2009, 9:78 http://www.biomedcentral.com/1471-2458/9/78
Page 7 of 12
(page number not for citation purposes)
tance travelled is related along both axes of Figure 1,
showing that children travel further, despite being largely
non-white: a category that generally travels less.
Factors predicting extra travel
Half of the individuals (1980/3983) monitored chose to
travel to a facility further than their nearest clinic (Table
2). Logistic regression revealed that extra travel was related
to being aged under 20 years (P < 0.001), being on triple
or more therapy (P < 0.001), being a male infected by sex
between men (MSM) and relative level of deprivation by
urban category, with those in rural areas and the least
deprived urban areas being more likely to travel further (P
< 0.001). Combining nationality and ethnicity categories
did not significantly predict extra travel. This is because
variation due to ethnicity and nationality was already
accounted for by route of infection and deprivation (eth-
nic minority groups tend to be heterosexually infected
and live in poorer areas).
For those persons travelling to a facility further than their
nearest clinic (n = 1980), the extra distance travelled (dis-
tance to nearest clinic subtracted from actual distance
travelled) was calculated (Table 2). Independent predic-
tors of additional travel were taking complex therapy
(those on quadruple therapy travelled 4.1 km compared
with 3.3 km for those on no therapy, multiple compari-
son P < 0.05) and infection route where MSM travelled
significantly less (3.1 km) than the 'other' category that
included children infected from their mothers and blood/
blood product recipients (4.2 km, multiple comparisons
P < 0.05). There was a marginally non-significant overall
difference between ethnic groups (P = 0.071), and none of
the multiple comparisons achieved significance (P >
0.05). There was no difference between age or gender in
terms of additional travel after controlling for the other
variables. Extra travel distance correlated with level of
affluence, with those in the less urban category travelling
7.7 km further than their nearest clinic, compared to 2.3
Detrended correspondence analysis (DCA) bi-plot to visualise the relationships between demographic and infection variables  (listed in table 1) Figure 1
Detrended correspondence analysis (DCA) bi-plot to visualise the relationships between demographic and 
infection variables (listed in table 1). Axes 1 and 2 are the major axes of variation between individuals based on the inclu-
sion of all measured variables (such that those at opposite ends of an axis are the most different, hence those that are most 
similar can form identifiable groupings). Arrows along the axes illustrate the significant correlation between distance travelled 
and the axis score (Axis 1: Spearman's rs = -0.135, P < 0.001; Axis 2: Spearman's rs = 0.274, P < 0.001). The individuals are 
labelled by infection route (Blood = contaminated blood/blood products, Het = heterosexual, IDU = injecting drug use, MSM = 
men who have sex with men, MTC = mother to child).
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Table 2: Percentage travelling further than their nearest clinic and additional distance travelled$
Predicting travelling further Number of additional km
nd f %X 2 Adj OR (95% CI) Adjusted mean (95%CI)$ F
Age 3 38.7*** Excluded final model NS
Under 20 94 79 Reference category
20–34 1306 47 0.341 (0.196–0.595)***
35–49 2052 51 0.355 (0.204–0.618)***
50+ 531 51 0.321 (0.180–0.573)***
Level of antiretroviral therapy 2 37*** 6.4**
None 1333 53 Reference category 3.3 (2.9, 3.9)
Mono/dual/triple 1935 56 1.515 (1.307–1.757)*** 4.2 (3.7, 4.7)a
Quadruple or more 715 44 1.658 (1.372–2.004)*** 4.1 (3.5, 4.9)a
Route and sex 3 68.2*** 4.5**
Sex between men 2172 53 Reference category 3.1 (2.7, 3.7)a
Male heterosexual 575 41 0.630 (0.503–0.788)*** 4.1 (3.4, 4.9)a, b
Female heterosexual 951 45 0.758 (0.608–0.945)* 4.2 (3.6, 4.8)a, b
Other 285 67 1.359 (1.018–1.815)* 4.1 (3.4, 5.1)b
Deprivation and urban category 3 42.3*** 36***
Not urban, least deprived 150 59 1.846 (1.302–2.617)** 7.7 (5.8, 10.1)
Urban, least deprived 1192 56 1.533 (1.303–1.805)*** 4.2 (3.6, 4.8)
Urban, average 1347 51 1.347 (1.152–1.574)*** 3.0 (2.7, 3.4)
Urban, most deprived 1294 44 Reference category 2.3 (2.0, 2.6)
Ethnicity and residency 5 21.0** Excluded final model 2.0
British white 2618 53 4.6 (4.1, 5.1)a
British black African 419 46 4.3 (3.5, 5.2)a
British other/unknown 226 52 4.4 (3.4, 5.5)a
Asylum seeker 367 42 3.6 (2.9, 4.5)a
Overseas student 109 44 3.5 (2.4, 5.0)a
Other non national 244 48 3.1 (2.4, 4.0)a
Total 3983 50
Univariate Chi square analysis and multivariate logistic regression to predict extra travel. Indendent predictors of additional distance travelled determined by general linear modelling.
$Extra distance travelled: overall model F13,1956 = 16.2, P < 0.001, adjusted R2 = 0.091
$Adjusted means in the same group with the same letter do not significantly differ after post hoc analysis (Bonferroni multiple comparisons).
all means significantly different from each other after Bonferroni multiple comparisons
*** P < 0.001, ** P < 0.01, * P < 0.05BMC Public Health 2009, 9:78 http://www.biomedcentral.com/1471-2458/9/78
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km travelled by the most deprived (urban) category (P =
0.001).
Type of service chosen by those bypassing local services
The urban categories were more likely to bypass a local
service in order to access a centre of excellence/specialist
centre, and travelled less in order to do so (Table 3). While
persons from the most deprived areas, who bypassed local
care to access a centre of excellence, only travelled an addi-
tional 3.6 km, those from less urban and least deprived
areas travelled substantially further (18.6 km and 8.6 km
respectively). Compared to the less urban group, all cate-
gories of urban dwellers were more likely to access a centre
of excellence/specialist centre (Table 4). The use of triple
therapy also predicted visits to centres of excellence, while
ethnicity and resident status did not (Table 4).
Discussion
Historically, UK residents with HIV have been able to
choose where they access their care. As such, HIV treat-
ment could be considered in some ways a model for
examining the consequences of patient 'choice' on health
services. Here we show a large variation in the amount of
travel by different groups of people with HIV. Those resid-
ing in disadvantaged areas travel significantly less per trip,
and are less likely to travel further than their nearest clinic,
compared with those in relatively more affluent areas.
This suggests that relatively wealthy individuals exercise
greater choice about where they receive their HIV care. The
Table 3: Association between type of service used, distance travelled and deprivation and urbanisation category for those (n = 1980) 
bypassing their local service*
Deprivation and urban category
Service use Not urban, least 
deprived
Urban least 
deprived
Urban, average 
deprivation
Urban, most 
deprived
Total
Centre of 
excellence/specialist 
service only#
% (n) 22.7 (20) 41.7 (275) 40.7 (277) 38.3 (212) 39.6 (784)
Mean km (95%CI) 18.64 (11.54, 30.13) 8.55 (7.58, 9.64) 5.34 (4.74, 6.02) 3.58 (3.05, 4.2) 5.84 (5.4, 6.33)
Large centre only$ % (n) 18.2 (16) 17.6 (116) 13.8 (94) 15.4 (85) 15.7 (311)
Mean km (95%CI) 14.52 (8.81, 23.94) 5.84 (4.88, 7) 4.6 (3.41, 6.21) 2.76 (2.09, 3.65) 4.64 (4.04, 5.34)
Smaller centre 
only@
% (n) 38.6 (34) 21.5 (142) 18.7 (127) 15.6 (86) 19.6 (389)
Mean km (95%CI) 5.84 (3.69, 9.26) 4.55 (3.58, 5.79) 3.84 (3.08, 4.79) 3.96 (2.87, 5.45) 4.24 (3.69, 4.88)
Subsidiary service 
only£
% (n) 1.1 (1) 0.2 (1) 0.4 (3) 0.4 (2) 0.4 (7)
Mean km (95%CI) 2.38 (0.69, 8.21)
More than one 
including 
excellence/specialist
% (n) 8.0 (7) 13.8 (91) 18.4 (125) 21.3 (118) 17.2 (341)
Mean km (95%CI) 30.74 (17.56, 53.81) 9.83 (7.89, 12.25) 5.79 (4.93, 6.79) 5.45 (4.55, 6.52) 6.72 (5.96, 7.58)
More than one 
standard service
% (n) 11.4 (10) 5.2 (34) 7.9 (54) 9.0 (50) 7.5 (148)
Mean km (95%CI) 32.97 (18.46, 58.88) 10.54 (6.66, 16.7) 6.93 (4.29, 11.2) 6.08 (3.92, 9.45) 8.13 (6.27, 10.54)
*significant: Chi square = 56.9, df = 12, p < 0.0001, excluding those attending subsidiary services only
#North Manchester General Infectious Disease Unit (1,500 patients), and all paediatric and haematology units
$Centre with over 300 HIV positive patients
@ Centre with fewer than 300 HIV positive patients
£Non-prescribing centreBMC Public Health 2009, 9:78 http://www.biomedcentral.com/1471-2458/9/78
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relationship between affluence and clinic choice is com-
plex, however, since affluent individuals who bypass local
services appear, from our data, to be more likely to travel
to a small centre for care than to a (large) centre of excel-
lence or specialist centre. We suggest they travel further
than they need to in order to protect their confidentiality.
This appears to be particularly the case for those residing
in more rural areas and replicates findings from studies in
the USA [11]. We were unable to assess the relative effect
of affluence on distance travelled by rural dwellers
because of the negligible number of economically
deprived HIV-infected patients living in rural communi-
ties.
Our findings are consistent with a review of previous stud-
ies on various conditions that determined willingness to
travel was related to being male, being affluent and having
more need for specialist care [9]. Of the HIV positive
patients monitored here, those taking quadruple or more
therapy can be assumed to require more specialist care,
and these individuals travelled further per trip (4.0 km vs
5.3 km). Those with specialist needs such as children, hae-
mophiliacs or those taking more complex drug therapy
also had a higher per trip and yearly travel to access treat-
ment. The same was true of the other variables, which
demonstrated relationships between willingness (or abil-
ity) to travel and gender/infection route, affluence and
complexity of treatment (level of antiretroviral therapy).
In New York, admissions of patients travelling long dis-
tances outside their county was associated with younger
age groups, higher illness severity and fewer same-county
hospital resources [17]. Same-county admissions were
associated with non-white race and lack of insurance.
In terms of addressing inequalities in access to health care,
one positive finding emerged. Those in the most deprived
urban areas were more likely to have accessed specialist
care or care from an urban centre of excellence despite
having travelled less and having been less likely to travel
further than their local clinic. This reflects the placement
the region's largest source of excellent/specialist care,
which is located conveniently close to some of the most
deprived areas. The experience of patients in north west
England may not, therefore, replicate that of others living
in deprived areas without similar close access to high
quality services. In the USA, when transport was provided
free of charge and costs reimbursed for participants need-
ing assistance, increased distance to care did not decrease
utilisation of HIV treatment programmes [13].
In this study, those with children infected with HIV suf-
fered the greatest burden of travel when accessing special-
ist paediatric care. Children with HIV were more likely to
travel to a clinic other than the nearest one and travelled
further in a year. Distance travelled for care in chronically
ill children contributes to stress in family life [18]. Added
to this, two thirds of children aged less than 15 years with
HIV live in the poorest fifth of the region studied. For
these families, travelling long distances for hospital care is
likely to be a significant financial strain.
Access to health care is complex and cannot be explained
solely by distance to services. Perceptions of barriers,
knowledge of services and modes of transport are all
related to accessibility [9]. The analysis presented here is
based on simple (straight line) distance, which is an intu-
itive and commonly used measure used to approximate
distance along a road or public transport network [14].
For longer distances, this straight-line distance is a good
representation of travel time [19], but for short urban dis-
tances, particularly in areas likely to be congested,
straight-line travel is less accurate. The two alternatives,
time taken to drive and use of public transport, were not
used because these data were not gathered in these rou-
tinely collected surveillance data. In particular, rates of car
use may be low because the majority of individuals with
HIV live in the poorest parts of the study region. The anal-
ysis in this paper is limited to those individuals for whom
valid postcode data were supplied. The use of postcode
centroids are recognised to be less accurate in lower den-
sity areas as the same postcode is shared by people living
at greater distances [20]. In our study, this limitation may
mask a range of distances travelled but is unlikely to cause
a systematic bias in any one direction. While the com-
pleteness of postcode data overall was good (85%), qual-
ity varied by clinic and this led to a smaller proportion of
individuals from some parts of the region being included
in the dataset. It would be useful to conduct a similar anal-
ysis on a national UK dataset, since individuals who trav-
elled between regions for their HIV care were not included
in this analysis. Another factor not available was distance
between treatment centre and place of work; individuals
with an occupation may have selected a clinic conven-
iently accessible from work [14].
Conclusion
Distance travelled, and type of services used by residents
of north west England with HIV, were associated with
socioeconomic status, after accounting for ethnicity, route
of infection and age. Thus despite offering an 'equitable'
service to people living with HIV, travel costs appear to
selectively advantage those with higher income. Policy
makers, planners and service providers need to recognise
travel remains a barrier to HIV access and care despite
opportunities for 'free-choice'.
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Table 4: Percentage of those (n = 1980) who bypass a local service to access a centre of excellence or specialist service, by 
demographics and infection route
Chi Square Logistic Regression
nd f % X 2 P Adj odds ratio (95% CI) P
Age 54.6 <0.001
Under 20 74 3 87.8 Ref 0.015
20–34 603 1 47.4 0.612 (0.25, 1.502) 0.284
35–49 1038 1 59.8 0.882 (0.36, 2.159) 0.783
50+ 265 1 57.7 0.772 (0.304, 1.959) 0.586
Route and sex 100.7 <0.001
Sex between men 1121 3 51.3 Ref <0.001
Male heterosexual 236 1 57.2 1.071 (0.758, 1.515) 0.697
Female heterosexual 431 1 56.1 1.032 (0.739, 1.441) 0.854
Other 192 1 90.1 8.057 (4.597, 14.122) <0.001
Deprivation and urban category 28.2 <0.001
Not urban, least deprived 88 3 30.7 Ref <0.001
Urban, least deprived 659 1 55.5 2.703 (1.602, 4.561) <0.001
Urban, average 680 1 59.1 3.607 (2.133, 6.100) <0.001
Urban, most deprived 553 1 59.7 3.622 (2.123, 6.180) <0.001
Ethnicity and residency 19.7 0.001
British white 1350 5 54.4 Ref 0.032
British black African 193 1 63.7 1.22 (0.805, 1.850) 0.348
British other/unknown 118 1 57.6 0.931 (0.600, 1.443) 0.748
Asylum seeker 153 1 58.2 1.069 (0.683, 1.673) 0.771
Overseas student 48 1 81.3 3.953 (1.774, 8.808) 0.001
Other non national 118 1 61.0 1.127 (0.689, 1.842) 0.634
Level of antiretroviral therapy 154.4 <0.001
None 568 2 35.4 Ref <0.001
Mono/dual/triple 1019 1 67.3 3.56 (2.821, 4.491) <0.001
Quad or more 393 1 60.6 2.576 (1.940, 3.420) <0.001
Total 1980 56.8
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IMD: index of multiple deprivation; MSM: men who have
sex with men.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
PAC made a substantial contribution towards conception,
design and analysis of paper. JD participated in concep-
tion, design, data monitoring and preliminary analysis.
CPW participated in final analysis and interpretation of
data. MAB contributed to the conception and critical eval-
uation of content. KT contributed expertise on analysis of
health inequalities and critical evaluation of content. QS
participated in the design and acquisition of data. PPH
participated in the interpretation of data, and to the draft-
ing and revision of the paper, and all authors read and
approved the final manuscript.
Additional material
Acknowledgements
We are very grateful to all staff in HIV treatment centres for providing data 
and Hannah Madden, Leighton Jones and Suzy Hargreaves for collating data. 
Other staff in the Centre for Public Health at Liverpool John Moores Uni-
versity (especially Sharon Schofield and Diana Leighton) provided support. 
We would also like to thank staff in the North West Public Health Observ-
atory for providing expertise and geographical/socioeconomic datasets 
(particularly Neil Potter and Sacha Wyke), and Eduardo Fé-Rodriguez for 
statistical advice. The North West HIV monitoring system is funded by the 
primary care trusts in the North West. Finally, we acknowledge the con-
structive comments of the three referees (Fiona Burns, Miguel Goncalves 
and Janice Probst), which have greatly improved this paper.
References
1. Hart JT: The inverse care law.  Lancet 1971, 1(7696):405-412.
2. Adamson J, Ben-Shlomo Y, Chaturvedi N, Donovan J: Ethnicity,
socio-economic position and gender–do they affect reported
health-care seeking behaviour?  Soc Sci Med 2003,
57(5):895-904.
3. Dixon A, Le Grand J: Is greater patient choice consistent with
equity? The case of the English NHS.  J Health Services Research
2006, 11(3):162-166.
4. Fryer GE Jr, Drisko J, Krugman RD, Vojir CP, Prochazka A, Miyoshi
TJ, Miller ME: Multi-method assessment of access to primary
medical care in rural Colorado.  J Rural Health 1999,
15(1):113-121.
5. Piette JD, Moos RH: The influence of distance on ambulatory
care use, death, and readmission following a myocardial inf-
arction.  Health Serv Res 1996, 31(5):573-591.
6. Burge P, Devlin N, Appleby J, Rohr C, Grant J: Do patients always
prefer quicker treatment?: a discrete choice analysis of
patients' stated preferences in the london patient choice
project.  Appl Health Econ Health Policy 2004, 3(4):183-194.
7. Liu JJ, Bellamy GR, McCormick M: Patient bypass behavior and
critical access hospitals: implications for patient retention.  J
Rural Health 2007, 23(1):17-24.
8. Department of Health: Building on the best: choice, responsive-
ness and equity in the NHS.  London: The Stationery Office; 2003. 
9. Exworthy M, Peckham S: Access, choice and travel. Implications
for Health Policy.  Social Policy Admin 2006, 40(3):267-287.
10. Fiscella K, Shin P: The inverse care law: implications for health-
care of vulnerable populations.  J Ambul Care Manage 2005,
28(4):304-312.
11. Heckman TG, Somlai AM, Peters J, Walker J, Otto-Salaj L, Galdabini
CA, Kelly JA: Barriers to care among persons living with HIV/
AIDS in urban and rural areas.  AIDS Care 1998, 10(3):365-375.
12. Burnam MA, Bing EG, Morton SC, Sherbourne C, Fleishman JA, Lon-
don AS, Vitiello B, Stein M, Bozzette SA, Shapiro MF: Use of mental
health and substance abuse treatment services among
adults with HIV in the United States.  Arch Gen Psychiatry 2001,
58(8):729-736.
13. Whetten R, Whetten K, Pence BW, Reif S, Conover C, Bouis S: Does
distance affect utilization of substance abuse and mental
health services in the presence of transportation services?
AIDS Care 2006, 18(Suppl 1):S27-34.
14. Guagliardo MF: Spatial accessibility of primary care: concepts,
methods and challenges.  Int J Health Geogr 2004, 3(1):3.
15. Jongman R, Braak CT, Tongeren OV, Eds: Data analysis in com-
munity and landscape ecology.  Cambridge: Cambridge Univer-
sity Press; 1995. 
16. McCune B, Mefford MJ: Multivariate analysis of ecological data.
In PC-ORD version 4.1 edition Gleneden Beach, Oregon, USA. MjM
Software; 1999. 
17. Basu J, Cooper J: Out-of-area travel from rural and urban
counties: a study of ambulatory care sensitive hospitaliza-
tions for New York State residents.  J Rural Health 2000,
16(2):129-138.
18. Yantzi N, Rosenberg MW, Burke SO, Harrison MB: The impacts of
distance to hospital on families with a child with a chronic
condition.  Soc Sci Med 2001, 52(12):1777-1791.
19. Phibbs CS, Luft HS: Correlation of travel time on roads versus
straight line distance.  Med Care Res Rev 1995, 52(4):532-542.
20. Ward MH, Nuckols JR, Giglierano J, Bonner MR, Wolter C, Airola M,
Mix W, Colt JS, Hartge P: Positional accuracy of two methods of
geocoding.  Epidemiology 2005, 16(4):542-547.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/9/78/prepub
Additional File 1
The F statistic. Definition of the F statistic used in Analysis of Variance 
and related techniques.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2458-9-78-S1.doc]